158 related articles for article (PubMed ID: 4620294)
1. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
[No Abstract] [Full Text] [Related]
2. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.
Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4283482
[No Abstract] [Full Text] [Related]
3. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Girling DJ
Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
[No Abstract] [Full Text] [Related]
4. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
Aquinas M
Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
[No Abstract] [Full Text] [Related]
5. Results after retreatment of advanced pulmonary tuberculosis with rifampin and other drugs.
Pines A
Am Rev Respir Dis; 1971 Jul; 104(1):126-7. PubMed ID: 4104090
[No Abstract] [Full Text] [Related]
6. Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972.
Steiner P; Rao M; Victoria M; Steiner M
Am Rev Respir Dis; 1974 Sep; 110(3):306-11. PubMed ID: 4213311
[No Abstract] [Full Text] [Related]
7. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Somner AR; Selkon JB; Walton M; White AB
Tubercle; 1971 Dec; 52(4):266-75. PubMed ID: 5143922
[No Abstract] [Full Text] [Related]
8. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regimens of chemotherapy for pulmonary tuberculosis--second report. A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation.
Tubercle; 1974 Sep; 55(3):169-92. PubMed ID: 4220080
[No Abstract] [Full Text] [Related]
9. [Internal medicine treatment of pulmonary tuberculosis].
Schaich W
Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
[No Abstract] [Full Text] [Related]
10. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
Horsfall PA
Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
[No Abstract] [Full Text] [Related]
11. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
12. [Fever and thin-walled cavitary lung lesions].
Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
[No Abstract] [Full Text] [Related]
13. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
Zierski M
Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
[No Abstract] [Full Text] [Related]
14. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
[No Abstract] [Full Text] [Related]
16. Treatment of patients with drug-resistance in economically developed countries.
Crofton J
Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
[No Abstract] [Full Text] [Related]
17. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794
[No Abstract] [Full Text] [Related]
18. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Trébucq A; Rieder HL
Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
[No Abstract] [Full Text] [Related]
19. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong.
Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248
[TBL] [Abstract][Full Text] [Related]
20. A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1980 Sep; 122(3):417-24. PubMed ID: 7416617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
